New Document top_band
 
Business Standard

Lupin gets USFDA nod to market oral contraceptive

The sales of the tablet were approximately $103.6 million in the US market

Read more on:    Lupin | Usfda | Lutera Tablet
Related News

Pharma major Ltd has received the final approval from the United States Food and Drugs Administration (USFDA) to market a generic version of an oral conceptive called Lutera Tablets.

The sales of the tablet were approximately $103.6 million in the US market and Lupin will begin marketing the generic version shortly, the company said.

Lupin is the fifth largest generics player in the US with a share of 5.1%. It is a significant player in the cardiovascular, diabetology, asthma and pediatric segments, holding global leadership in the anti-tuberculosis area.

Read more on:   
|
|

Read More

Suzlon, Tanti, 4 company execs settle charges with Sebi

After they together paid Rs 12 lakh to settle charges related to alleged delay in amending insider trading norms

Quick Links

Advertisement

Back to Top